Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436550 · ClinicalTrials.gov registry record
Assessment of Portal Hypertension With Multiparametric MRI
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 69
- Enrollment target
NCT03436550 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 69 participants.
The verdict
NCT03436550 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether new multiparametric magnetic resonance imaging (MRI) methods (including diffusion-weighted MRI, dynamic contrast-enhanced MRI, MR elastography and phase-contrast imaging) can be useful in assessing liver damage and degree of portal hypertension (a complication of advanced liver fibrosis and cirrhosis) secondary to chronic liver disease, compared to ultrasound measurement of liver stiffness \[acoustic radiation force impulse (ARFI) ultrasound\] and routine blood tests. MRI uses magnetic fields to look at soft tissues in the body. This study will ultimately help to determine whether these methods will be useful in identifying liver disease and their complications that cannot be well-understood using current liver MRI techniques.
Interventions
- PROCEDURE mpMRI
- PROCEDURE ARFI US
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2022-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436550
The ClinicalTrials.gov registry entry for NCT03436550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mpMRI is the first listed.
NCT03436550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03436550 about?
NCT03436550 is a clinical study titled "Assessment of Portal Hypertension With Multiparametric MRI". The purpose of this study is to determine whether new multiparametric magnetic resonance imaging (MRI) methods (including diffusion-weighted MRI, dynamic contrast-enhanced MRI, MR elastography and phase-contrast imaging) can be useful in assessing liver damage and degree of portal hypertension (a co...
What is the current status of trial NCT03436550?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2018-03-20. Estimated completion is 2022-07-19.
What interventions are being tested in trial NCT03436550?
The interventions under investigation include: mpMRI (PROCEDURE), ARFI US (PROCEDURE).
Who is sponsoring clinical trial NCT03436550?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.